FDA stresses birth defect risks with Roche drug

May 16, 2008 By MATTHEW PERRONE, AP Business Writer

(AP) -- Health regulators warned again Friday that Roche and Novartis drugs prescribed to organ transplant patients can cause miscarriages and birth defects when used by pregnant women.

Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .

Similar stories from PHYSorg:

Pregnancy and birth: Safe for women with kidney transplants

Sep 24, 2009 | not rated yet | 0

Miscarriage and infertility treatment increase pre-eclampsia risk

Dec 18, 2008 | not rated yet | 0

Switzerland restricts use of GlaxoSmithKline swine flu vaccine

Oct 30, 2009 | 4 / 5 (1) | 0

FDA issues Myfortic tablets safety alert

Nov 28, 2007 | not rated yet | 0

Britain to outlaw most private organ transplants

Jul 31, 2009 | 4 / 5 (1) | 1

Rate this story - 5 /5 (1 vote)

rank
1
2
3
4
5

view popular

Other News

Transcendental Meditation helped heart disease patients lower cardiac disease risks by 50 percent

Medicine & Health / Health

50 minutes ago | 5 / 5 (1) | 0

Patients with coronary heart disease who practiced the stress-reducing Transcendental Meditation® technique had nearly 50 percent lower rates of heart attack, stroke, and death compared to nonmeditating controls, according ...

New advice: Skip mammograms in 40s, start at 50

Medicine & Health / Cancer

50 minutes ago | not rated yet | 0

(AP) -- Most women don't need a mammogram in their 40s and should get one every two years starting at 50, a government task force said Monday. It's a major reversal that conflicts with the American Cancer ...

Wistar researchers show targeting 'normal' cells in tumors slows growth

Medicine & Health / Cancer

27 seconds ago | not rated yet | 0

Targeting the normal cells that surround cancer cells within and around a tumor is a strategy that could greatly increase the effectiveness of traditional anti-cancer treatments, say researchers at The Wistar Institute.

First near-total face and upper-jaw transplant appears successful

Medicine & Health / Other

50 minutes ago | 4 / 5 (1) | 0

More than a year and a half following the first near-total face and upper jaw transplant, the donor tissue appears successfully integrated, according to a report in the November/December issue of Archives of Facial Plastic Su ...

New cause of osteoporosis: Mutation in a miroRNA

Medicine & Health / Research

30 minutes ago | 5 / 5 (1) | 0

Many biological processes are controlled by small molecules known as microRNAs, which work by suppressing the expression of specific sets of genes. Xiang-Hang Luo and colleagues, at Second Xiangya Hospital of Central South ...